Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial.

Song-Yang WuYing XuLi ChenLei FanXiao-Yan MaShen ZhaoXiao-Qing SongXin HuWen-Tao YangWen-Jun ChaiXiao-Mao GuoXi-Zi ChenYan-Hui XuXiao-Yu ZhuJian-Jun ZouZhong-Hua WangYi-Zhou JiangZhi-Ming Shao

Published in: Molecular cancer (2022)

ClinicalTrials.gov: NCT04129996 . Registered 11 October 2019.

Keyphrases

endothelial cells
clinical trial
study protocol
phase iii
current status
vascular endothelial growth factor
phase ii